NASDAQ: AQST
Aquestive Therapeutics Inc Stock Ownership - Who owns Aquestive Therapeutics?

Insider buying vs selling

Have Aquestive Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Cassie JungChief Operating Officer2025-10-1567,575$7.01
$473.70kSell
Peter E. BoydSVP IT HR Communications2025-10-1510,000$7.00
$70.00kSell
Carl N. KrausChief Medical Officer2025-10-1520,272$7.00
$141.90kSell
Cassie JungChief Operating Officer2025-10-1525,000$3.10
$77.58kBuy
Daniel BarberPresident and CEO2025-09-2691,343$6.03
$551.16kSell
Peter E. BoydSVP IT HR Communications2025-09-2610,000$6.30
$63.00kSell
Daniel BarberPresident and CEO2025-09-19400$6.00
$2.40kSell
Peter E. BoydSVP IT HR Communications2025-09-0515,000$5.30
$79.50kSell
Cassie JungChief Operating Officer2025-09-0425,000$3.15
$78.75kBuy
Cassie JungChief Operating Officer2025-09-0462,180$5.00
$310.90kSell

1 of 3

AQST insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AQST insiders and whales buy or sell their stock.

AQST Shareholders

What type of owners hold Aquestive Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Bratton Capital Management LP8.04%9,810,958$60.73MInstitution
Blackrock Inc5.35%6,525,683$40.39MInstitution
Rtw Investments LP5.12%6,250,000$38.69MInstitution
Vanguard Group Inc4.64%5,662,132$35.05MInstitution
Perceptive Advisors LLC3.08%3,760,099$23.28MInstitution
Ecor1 Capital LLC2.15%2,625,000$16.25MInstitution
Samsara Biocapital LLC2.05%2,500,000$15.48MInstitution
Geode Capital Management LLC1.71%2,087,948$12.92MInstitution
Douglas K. Bratton1.61%1,963,890$12.16MInsider
State Street Corp1.31%1,602,216$9.92MInstitution

1 of 3

AQST vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AQST54.16%6.23%Net SellingNet Selling
ORGO6.93%93.07%Net BuyingNet Selling
TLRY10.91%1.84%Net Buying
ESPR45.18%17.13%Net SellingNet Selling
IRWD69.65%30.35%Net SellingNet Selling

Aquestive Therapeutics Stock Ownership FAQ

Who owns Aquestive Therapeutics?

Aquestive Therapeutics (NASDAQ: AQST) is owned by 54.16% institutional shareholders, 6.23% Aquestive Therapeutics insiders, and 39.62% retail investors. Douglas K. Bratton is the largest individual Aquestive Therapeutics shareholder, owning 1.96M shares representing 1.61% of the company. Douglas K. Bratton's Aquestive Therapeutics shares are currently valued at $12.18M.

If you're new to stock investing, here's how to buy Aquestive Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.